1471-2490

BMC Urology

Springer (Biomed Central Ltd.)

View prefix report (10.1186)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 1935 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact1935 DOIs
2

Add abstracts to 1308 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact1308 DOIs
3

Add license metadata to 157 records

License metadata tells indexers and readers how each article may be reused.

Low impact157 DOIs

DOIs for this ISSN

Showing the top 5 of 2615 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Do African-American men need separate prostate cancer screen… (10.1186/s12894-016-0137-7)
Abstract ORCID License
155.94 119
2 Perineural invasion as an independent predictor of biochemic… (10.1186/s12894-018-0319-6)
Abstract ORCID License
134.43 61
3 The R.I.R.S. scoring system: An innovative scoring system fo… (10.1186/s12894-017-0297-0)
Abstract ORCID License
132.26 57
4 Frequent mismatch-repair defects link prostate cancer to Lyn… (10.1186/s12894-016-0130-1)
Abstract ORCID License
131.69 56
5 Urinary incontinence, mental health and loneliness among com… (10.1186/s12894-017-0214-6)
Abstract ORCID License
130.53 54
6 The urine dipstick test useful to rule out infections. A met… (10.1186/1471-2490-4-4)
Abstract ORCID
128.76 375
7 miR-221-5p enhances cell proliferation and metastasis throug… (10.1186/s12894-018-0325-8)
Abstract ORCID License
128.70 51
8 A novel stepwise micro-TESE approach in non obstructive azoo… (10.1186/s12894-016-0138-6)
Abstract ORCID License
128.07 50
9 Comparison of the efficacy and safety of URSL, RPLU, and MPC… (10.1186/s12894-017-0236-0)
Abstract ORCID License
128.07 50
10 Association of lower urinary tract symptoms and OAB severity… (10.1186/s12894-017-0294-3)
Abstract ORCID License
123.99 44
11 Abiraterone acetate in metastatic castration-resistant prost… (10.1186/s12894-016-0132-z)
Abstract ORCID License
123.26 43
12 Clinical characteristics of XP11.2 translocation/TFE3 gene f… (10.1186/s12894-016-0154-6)
Abstract ORCID License
121.74 41
13 PD-L1 expression in papillary renal cell carcinoma (10.1186/s12894-016-0195-x)
Abstract ORCID License
121.74 41
14 Antihypertensive drugs use and the risk of prostate cancer:… (10.1186/s12894-018-0318-7)
Abstract ORCID License
121.74 41
15 Complications of circumcision in male neonates, infants and… (10.1186/1471-2490-10-2)
Abstract ORCID
121.08 263
16 Benign prostatic enlargement can be influenced by metabolic… (10.1186/s12894-017-0211-9)
Abstract ORCID License
120.96 40
17 Percutaneous nephrolithotomy versus retrograde intrarenal su… (10.1186/s12894-017-0200-z)
Abstract ORCID License
118.48 37
18 Management of large renal stones: laparoscopic pyelolithotom… (10.1186/s12894-017-0266-7)
Abstract ORCID License
118.48 37
19 Rethinking of ureteral stent removal using an extraction str… (10.1186/s12894-015-0114-6)
Abstract ORCID License
117.62 36
20 Lymphoepithelioma-like, a variant of urothelial carcinoma of… (10.1186/s12894-017-0224-4)
Abstract ORCID License
116.72 35
21 Intraoperative and postoperative feasibility and safety of t… (10.1186/s12894-017-0239-x)
Abstract ORCID License
113.89 32
22 Obesity is associated with increased risk of invasive penile… (10.1186/s12894-016-0161-7)
Abstract ORCID License
112.89 31
23 Neutrophil-lymphocyte ratio as a predictive biomarker for re… (10.1186/s12894-016-0192-0)
Abstract ORCID License
111.85 30
24 Characteristics and repair outcome of patients with Vesicova… (10.1186/s12894-016-0152-8)
Abstract ORCID License
110.78 29
25 Evaluation and treatment for ovotesticular disorder of sex d… (10.1186/s12894-017-0212-8)
Abstract ORCID License
110.78 29
26 Should manual detorsion be a routine part of treatment in te… (10.1186/s12894-017-0276-5)
Abstract ORCID License
110.78 29
27 Preoperative lipiodol marking and its role on survival and c… (10.1186/s12894-017-0199-1)
Abstract ORCID License
109.68 28
28 The susceptibility to fosfomycin of Gram-negative bacteria i… (10.1186/s12894-017-0222-6)
Abstract ORCID License
108.54 27
29 Multi-disciplinary surgical approach to the management of pa… (10.1186/s12894-016-0157-3)
Abstract ORCID License
107.35 26
30 Fulranumab in patients with interstitial cystitis/bladder pa… (10.1186/s12894-016-0193-z)
Abstract ORCID License
107.35 26
31 Antimicrobial peptides of the Cecropin-family show potent an… (10.1186/1471-2490-8-5)
Abstract ORCID
107.31 139
32 The MAPP research network: a novel study of urologic chronic… (10.1186/1471-2490-14-57)
Abstract ORCID
106.36 133
33 The MAPP research network: design, patient characterization… (10.1186/1471-2490-14-58)
Abstract ORCID
106.19 132
34 Bacteriophages for treating urinary tract infections in pati… (10.1186/s12894-017-0283-6)
Abstract License
105.53 128
35 Stereotactic body radiotherapy for organ-confined prostate c… (10.1186/1471-2490-10-1)
Abstract ORCID
105.19 126
36 Eviprostat has an identical effect compared to pollen extrac… (10.1186/s12894-015-0115-5)
Abstract ORCID License
104.85 24
37 Normal kidney size and its influencing factors - a 64-slice… (10.1186/1471-2490-9-19)
Abstract ORCID
104.32 121
38 Genetic polymorphisms in key hypoxia-regulated downstream mo… (10.1186/s12894-017-0201-y)
Abstract ORCID License
103.52 23
39 Real life persistence rate with antimuscarinic treatment in… (10.1186/s12894-017-0216-4)
Abstract ORCID License
103.52 23
40 Study protocol: patient reported outcomes for bladder manage… (10.1186/s12894-017-0286-3)
Abstract ORCID License
103.52 23
41 Prevalence, incidence and remission of urinary incontinence… (10.1186/1471-2490-13-27)
Abstract ORCID
103.22 115
42 Global expression of AMACR transcripts predicts risk for pro… (10.1186/s12894-016-0128-8)
Abstract ORCID License
102.13 22
43 Acceptability of dietary and physical activity lifestyle mod… (10.1186/s12894-017-0284-5)
Abstract ORCID License
102.13 22
44 Intravescical prostatic protrusion is a predictor of alpha b… (10.1186/s12894-018-0320-0)
Abstract ORCID License
102.13 22
45 Intravenous misplacement of the nephrostomy catheter followi… (10.1186/s12894-017-0233-3)
Abstract ORCID License
100.68 21
46 The EEF1A2 gene expression as risk predictor in localized pr… (10.1186/s12894-017-0278-3)
Abstract ORCID License
100.68 21
47 Psychometric properties of the expanded prostate cancer inde… (10.1186/s12894-017-0302-7)
Abstract ORCID License
100.68 21
48 miR-21 may acts as an oncomir by targeting RECK, a matrix me… (10.1186/1471-2490-12-14)
Abstract ORCID
99.78 98
49 The prostate cancer detection rates of CEUS-targeted versus… (10.1186/s12894-017-0213-7)
Abstract ORCID License
99.17 20
50 Anti-proliferative potential of Glucosamine in renal cancer… (10.1186/s12894-017-0221-7)
Abstract ORCID License
99.17 20